athyrium capital management  athyrium funds investor login aof i portal aof ii portal athyrium  our funds overview our funds our history aof ii in may  athyrium announced a final closing for the athyrium opportunities fund ii aof ii or the fund the fund has  of committed capital the fund is focused on making structured investments in the broader healthcare and life sciences sectors including pharmaceuticals biologics biotechnology specialty and generic pharmaceuticals medical devices and products laboratory and diagnostics products and services healthcare services and healthcare information technology the fund is focused on generating current income and capital gains and has significant flexibility in structuring its investments–possible transaction structures include loans or other highyielding credit investments with or without warrant coverage royalties or royaltybacked investments structured securities preferred stock or convertible securities the fund seeks to make attractive riskadjusted returns and looks to partner with management teams and to provide long term capital to assist in building their businesses the fund can also engage in secondary market transactions aof ii is a successor fund to the athyrium opportunities fund aof i which had a final closing in march 03 with  million of committed capital separate accounts since its founding athyrium has formed a number of separate account relationships in order to focus on specific opportunities within the life sciences sector nb athyrium llc served as a predecessor to the athyrium opportunities fund athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february 0 biofire diagnostics biofire filmarray september 0 verenium verenium various december 0 ironwood pharmaceuticals ironwood and forest laboratories linzess january 03 syncardia systems inc syncardia total artificial heart march 03 progenity inc progenity inc various genetic tests june 03 tria beauty inc tria beauty skincare products july 03 innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october 03 horizon pharma inc horizon pharma various nsaids and actimmune november 03 universal biosensors inc lifescan jj and siemens point of care poc diagnostics december 03 pernix therapeutics holdings inc pernix treximet and others february 04 ikaria inc ikaria inomax february 04 vivus inc vivus inc qsymia and stendraspedra february 04 synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march 04 retrophin inc alamo pharma services inc chenodal  thiola july 04 tecomet inc tecomet orthopedic and other contract manufacturing services december 04 zealand pharma as sanofi lyxumia december 04 lannett company inc lannett company inc generic pharmaceuticals december   this table lists all investments made by the athyrium opportunities fund athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february 0 biofire diagnostics biofire filmarray september 0 verenium verenium various december 0 ironwood pharmaceuticals ironwood and forest laboratories linzess january 03 syncardia systems inc syncardia total artificial heart march 03 progenity inc progenity inc various genetic tests june 03 tria beauty inc tria beauty skincare products july 03 innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october 03 horizon pharma inc horizon pharma various nsaids and actimmune november 03 universal biosensors inc lifescan jj and siemens point of care poc diagnostics december 03 pernix therapeutics holdings inc pernix treximet and others february 04 ikaria inc ikaria inomax february 04 vivus inc vivus inc qsymia and stendraspedra february 04 synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march 04 retrophin inc alamo pharma services inc chenodal  thiola july 04 tecomet inc tecomet orthopedic and other contract manufacturing services december 04 zealand pharma as sanofi lyxumia december 04 lannett company inc lannett company inc generic pharmaceuticals december   this table lists all investments made by the athyrium opportunities fund athyrium capital management and neuberger berman close  billion healthcare fund  neuberger berman incompatible browser to get the best possible experience using our website we recommend that you upgrade to a newer version or other web browser a list of the most popular web browsers can be found below just click on the icons to get to the download page browser cookies support your browser does not support cookies or they are not enabled cookies are required to access this site ok top united states not your country to access available investments and market insights please select your audience required personalize your experience in order to provide a completely personalized experience please select from the following optionsrequired please select a job role i would also like defined contribution specific content submit order cart you have unordered items in your cart  do not show this message again go to cart close username change our records show your email address may have changed do you want to update ityou will have to relogin back in  do not show this message again yes no terms and conditions accept   decline terms and conditions accept decline united states not your country select a site to access available investments and market insights please select your audience required select your region select your country select your site globalselect your country  style libraryimagesspacergif   nbathyrium opportunities fund iii lp  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors nbathyrium opportunities fund iii lp list of persons related to the company nbathyrium opportunities fund iii lp find out list of ceos founders board members and company directors of nbathyrium opportunities fund iii lp cik number 900company address  third avenue nd floor new york 0phone number   people related to nbathyrium opportunities fund iii lp namepositionstreetcitycountrytutrone anthony90 avenue of the americas 4nd floornew yorknyrice blake3 n saint paul street suite dallastxneira christian90 avenue of the americas 4nd floornew yorknymaughan kelly90 avenue of the americas 4nd floornew yorknymarlar kimberly3 n saint paul street suite dallastxkreamer kindal3 n saint paul street suite dallastxbiederman leila90 avenue of the americas 4nd floornew yorknyna nb alternatives advisers llc3 n saint paul street suite dallastxporat samuel90 avenue of the americas 4nd floornew yorknylong teale90 avenue of the americas 4nd floornew yorknyfeder yonah90 avenue of the americas 4nd floornew yorkny nbathyrium opportunities fund iii lp on the web neuberger berman raises  billion for third global private equity secondary fund incompatible browser to get the best possible experience using our website we recommend that you upgrade to a newer version or other web browser a list of the most popular web browsers can be found below just click on the icons to get to the download page browser cookies support your browser does not support cookies or they are not enabled cookies are required to access this site ok top united states not your country to access available investments and market insights please select your audience required personalize your experience in order to provide a completely personalized experience please select from the following optionsrequired please select a job role i would also like defined contribution specific content submit order cart you have unordered items in your cart  do not show this message again go to cart close username change our records show your email address may have changed do you want to update ityou will have to relogin back in  do not show this message again yes no terms and conditions accept   decline terms and conditions accept decline united states not your country select a site to access available investments and market insights please select your audience required select your region select your country select your site globalselect your country  style libraryimagesspacergif investments  fund ii  us select private opportunities fund about investment strategy our team services and fees about walsh  company us select i investments performance announcements key documents us select ii investments performance announcements key documents us select iii investments performance announcements key documents important information contact investments – us select ii investments – us select iiinfinite00t4 us select private opportunities fund ii usgasx was listed in april 03 and is fully committed having raised a total of us million  the cordish family invested usm alongside and on the same terms as fund ii in the us select private opportunities fund ii lp the portfolio currently includes twelve underlying fund managers diversified across the us economy lp commitment us million industry focus lower middlemarket manufacturing and business services companies read more lp commitment us million industry focus healthcare senior living read more lp commitment us million industry focus healthcare business services and industrial services read more lp commitment us million industry focus manufacturing services valueadd distribution media and healthcare read more lp commitment us million industry focus consumer business services industrial growth read more lp commitment us million industry focus healthcare consumer products and specialised business services read more lp commitment us million industry focus business services niche manufacturing and healthcare services read more lp commitment us million industry focus nonindustry specific read more lp commitment us0 million industry focus branded consumer products and retail read more lp commitment us million industry focus nonindustry specific read more lp commitment us0 million industry focus nonindustry specific read more lp commitment us million industry focus non industryspecific direct portfolio investment alongside leading specialist private equity funds read more us select iiinvestments performance announcements key documents pef30 quote  ares corporate opportunities fund iv lp  bloomberg markets error could not add to watchlist x  watchlist ares corporate opportunities fund iv lp pef30us inactive pef30us is inactive usd fund type private equity fund before its here its on the bloomberg terminal learn more fund type private equity fund objective  asset class focus private equity geographic focus  nav on   total assets  on   inception date  last dividend on   dividend indicated gross yield  fund managers  front load fee  back load fee  redemption fee  b fee  current mgmt fee  expense ratio  profile ares corporate opportunities fund iv lp is a 0 private equity fund currently investing the fund makes midmarket buyout investments in various sectors the fund makes investments within the united states and western europe address  phone  website  products  uob global capital uob global capital building partnership cultivating value welcome history about uob management approach capabilities products relationships commentary contact us new york office paris office singapore office products private equity direct asean china – the asean china investment fund lp had its final close in   the fund focuses its operations in the aseanchina growth corridor comprising the 0 memberstates of asean and the people’s republic of china  the fund targets privately negotiated equity and equity related investments in small and medium sized companies particularly those that can benefit from the rapidly expanding trade and investment ties between asean and china and their respective extraregional trading partners  a followon fund the asean china investment fund lp ii had its final close in   this fund will be substantially investing in the same geographies as fund i fund of funds europe– the hermes uob european private equity fund had its final close in  the fund is invested in a diversified portfolio of european private equity funds pan asian– the uob portfolio advisors pan asia select fund i ii and iii had their respective final closings in  9 and 0  the funds invest in private equity funds in the asia pacific region the funds invest in buyouts special situations growth capital and selectively in venture secondary and coinvestment opportunities in greater china singapore asean japan south korea india australia and new zealand real estate the huh us real estate income fund raised us3 million for investment in us core plus assets  the fund assembeled a portfolio of assets that provides stable distributable current income over the life of the fund additional returns may be generated through improving noi and disposing of assets with cap rate compression the strategy employs moderate leverage of not more than 0 and  is targeted to produce net investor irr of 0the fund’s investment strategy is to acquire inefficiently priced well located and well leased properties in the united states with primary focus on the eastern us long term leases and a focus on credit tenants will produce stable cash from the operations the funds portfolio consists of  about 0 grocery anchored retail and 0 industrial assets uob eagle rock multifamily property fund lp is a delaware limited partnership the fund raised about us 3  million which was deployed in a portfolio of stable income producing multifamily apartment communities in generating  current income for regular distribution targeting stable and robust equity returns of  3  net irrthe fund’s emphasis will is  on markets in the northeastern corridor in the united states between washington dc to the south and boston massachusetts to the north this is a specialized area of real estate requiring both the ability to identify and acquire on advantageous terms select properties but also to operate these properties the key is to ensure maximum occupancy control costs and capital maintenance and increase rentals over time this approach provides reliable yields with regular tax effective distributions and over time capital appreciation listed equity                     asiapacific– this strategy seeks to achieve longterm capital appreciation and regular income through investing in shares of companies listed on asianpacific emerging  developed markets asia ex japan– this strategy seeks to achieve longterm capital appreciation and regular income through investing in shares of companies listed on asian ex japan emerging  developed markets asian small cap– this strategy seeks to achieve longterm capital growth by investing primarily in small capitalization stocks and stockrelated securities issued by corporations in the asian ex japan emerging  developed markets greater china– this strategy seeks long term capital growth through investing in securities that have businesses in hong kong china and taiwan the main markets invested are the hong kong shanghai shenzhen and taiwan stock exchanges japan– this strategy seeks long term capital growth through investing in companies with assets in or revenue derived from japan us all cap– this strategy seeks to provide long term capital growth by investing primarily in us equities not limited to a particular market capitalization  the investment team focuses primarily on common stocks that it believes to be undervalued at the time of purchase relative to their intrinsic economic worth global equities– this strategy seeks to provide long term capital growth by investing global equities not limited to a particular market capitalization  the investment team focuses primarily on common stocks that it believes to be undervalued at the time of purchase relative to their intrinsic economic worth fixed income asian fixed income – this strategy seeks to provide stable current income and capital appreciation by investing in debt securities issued by asian corportations financial institutions governments and their agencies including money market instruments renminbi bond fund – this strategy seeks to generate fixed income returns and benefit from the potential appreciation of the renminbi over the medium term by investing primarily in renminbi denominated debt securities issued or distributed outside mainland china  the issuers of such securities include but are not limited to governments quasigovernment bodies international and multinational organizations banks and financial institutions and corporations emerging market debt – this strategy seeks to maximize returns with high yield and capital appreciation over the longer term in emerging markets debt investments and products hedge funds hedge funds marketed by uobgc affiliates include a series of single strategy longshort funds including a largemid cap fund and a focused portfolio fund  in addition a short duration credit opportunities fund and a multistrategy fund are available irish ucits platform uobgc through its whollyowned subsidiary uob global capital dublin ltd manages an irish based family of funds    the uob global strategies funds plc is an open ended umbrella type investment company with variable capital incorporated with limited liability under the laws of ireland within this ucits structure there are funds focused on greater china equities us equities us all cap stocks and global equities and renminbi bonds  these funds are available to nonus institutional investors and are registered in various jurisdictions including switzerland germany france italy the netherlands and the uk more information for nonus residents can be found at wwwuobglobalfundscom for swiss and german investors more information can be found at wwwfundinfocom       website search contact us new york  3933 paris 33 34 4 singapore  390 welcome  history  about uob  management  approach  capabilities  products  relationships  contact us  terms  conditions  site map  0 uob global capital llc all rights reservedwebsite by dart inc  web development  consulting